alprazolam has been researched along with oxybutynin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Alberti, I; Carrara, DN; Grenier, A; Kraus, H | 1 |
| Boix, A; Colom, H; Domenech, J; Lauroba, J; Soler, LI | 1 |
2 review(s) available for alprazolam and oxybutynin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmaceutical development and clinical effectiveness of a novel gel technology for transdermal drug delivery.
Topics: Administration, Cutaneous; Alprazolam; Animals; Anti-Anxiety Agents; Drug Delivery Systems; Estradiol; Female; Gels; Humans; Hypogonadism; Male; Mandelic Acids; Norethindrone; Parasympatholytics; Progesterone Congeners; Testosterone; Urinary Bladder, Neurogenic | 2005 |
2 other study(ies) available for alprazolam and oxybutynin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization.
Topics: Adhesives; Administration, Cutaneous; Alprazolam; Chemistry, Pharmaceutical; Drug Delivery Systems; Humans; Permeability; Skin; Skin Absorption; Transdermal Patch; Water | 2012 |